Thalia Therapeutics PLC
LLSE:THAT0.60
GBX
0.00
(0.00%)
Share Statistics
As of December 31, 2025, Thalia Therapeutics PLC has 832.28M shares outstanding.
| Shares Outstanding | 832.28M |
Financial Position
As of December 31, 2025, Thalia Therapeutics PLC maintains a current ratio of 11.93, meaning it holds 11.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.93 |
| Quick Ratio | 11.02 |
Stock Price Statistics
GBXThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 0.61 |
Balance Sheet
GBXThese figures are as of December 31, 2025. Total book value stands at 106.99M, with working capital of 107.05M providing operational flexibility.
| Cash & Cash Equivalents | 107.93M |
| Net Debt | -107.93M |
| Equity (Book Value) | 106.99M |
| Book Value Per Share | 0.13 |
| Working Capital | 107.05M |
Stock Splits
Thalia Therapeutics PLC's most recent stock split took place on May 3, 2017 with a 4:1 split ratio.
| Last Split Date | 5/3/2017 |
| Split Ratio | 4:1 |